Abstract:Introduction: Direct cardiac reprogramming emerges as a promising strategy for in situ conversion of fibroblasts into induced cardiomyocyte-like cells (iCMs). While the conversion of mouse fibroblasts into functional, beating iCMs has been achieved efficiently, the reprogramming of human iCMs remains challenging, particularly their maturation with existing transcription factor combinations. Given the pivotal role of epigenetic regulation in this process, our study sought to leverage heart-specific epigenetic factors alongside cardiac-enriched transcription factors to enhance cardiac maturation, thereby yielding more reliable human iCMs. Result: Through analyzing the proteomic data across various human tissues, we found that while many epigenetic factors are broadly expressed, SMYD1 is uniquely heart-specific. To determine its involvement in reprogramming, we overexpressed SMYD1 and evaluated the reprogramming efficiency and iCM quality via flow cytometry, immunofluorescence staining, and transcriptome analysis. Notably, we observed an increase in iCMs expressing sarcomere markers, such as α-myosin heavy chain and α-actinin, as well as the ventricular specific myosin-light-chain 2v in SMYD1-treated group. Gene set enrichment analysis of RNA-sequencing data further indicated that SMYD1-induced iCMs exhibit ventricular gene signatures. Additionally, we discovered moderate activation of SMYD1 in mature iCMs generated with MEF2C, GATA4, TBX5, and TBX20. TBX20 is the key factor that leads to the co-binding of MEF2C, TBX5, and TBX20 on the SMYD1 promoter region and increases active histone marks, H3K27ac and H3K4me1. Rescue assay and transcriptomic comparison confirmed SMYD1 as the primary downstream target of TBX20 in promoting iCM functional maturation. Mechanistically, SMYD1 directly interacts with MEF2C and GATA4 to modify histone marks on cardiac regulatory regions. Conclusion: Our study provides comprehensive phenotypic and molecular evidence of SMYD1’s role as a cardiac-specific regulator during direct cardiac reprogramming. By interacting with key reprogramming factors and rewriting histone marks, SMYD1 significantly advances the maturation of human iCMs towards a ventricular subtype identity.

14-3-3 binding motif phosphorylation disrupts Hdac4-organized condensates to stimulate cardiac reprogramming

EED Orchestration of Heart Maturation Through Interaction with HDACs is H3K27me3-independent.

Histone Deacetylases in Modulating Cardiac Disease and Their Clinical Translational and Therapeutic Implications

Down-regulation of Beclin1 promotes direct cardiac reprogramming

CHD4 and SMYD1 repress common transcriptional programs in the developing heart

Insight into the regulatory mechanism of dynamic chromatin 3D interactions during cardiomyocyte differentiation in Human

Abstract We033: Heart-Specific Histone Methyltransferase SMYD1 Promotes Cardiac Maturation in the Direct Conversion of Human Fibroblasts into Cardiomyocytes.

RB AND P130 CONTROL THE POST-MITOTIC PHENOTYPE IN ADULT HEART MUSCLE BY RECRUITING THE HETEROCHROMATIN PROMOTING FACTOR HP1γ TO GROWTH ASSOCIATED GENES

Abstract P324: Brd4 Degradation Enhances Cardiac Reprogramming And Regeneration By Inhibiting JAK/STAT Pathway

Coactivator condensation drives cardiovascular cell lineage specification

HDAC7 promotes cardiomyocyte proliferation by suppressing Myocyte Enhancer Factor 2

Inhibition of P300-Hat Results in a Reduced Histone Acetylation and Down-Regulation of Gene Expression in Cardiac Myocytes

4-phenylbutyrate exerts stage-specific effects on cardiac differentiation via HDAC inhibition

Structural insights into the HDAC4–MEF2A–DNA complex and its implication in long-range transcriptional regulation

Deacetylase‐dependent and ‐independent role of HDAC3 in cardiomyopathy

WNT signaling promotes Nkx2.5 expression and early cardiomyogenesis via downregulation of Hdac1.

CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors

Nucleosome repositioning in cardiac reprogramming

HDAC4 promotes Pax7-dependent satellite cell activation and muscle regeneration.

14-3-3 Proteins Regulate Glycogen Synthase 3 Beta Phosphorylation And Inhibit Cardiomyocyte Hypertrophy